Exponent Inc Stock Price, News & Analysis

Exponent (NASDAQ: EXPO) reported its Q1 2025 financial results with total revenues remaining relatively flat at $145.5 million compared to Q1 2024. Net income decreased to $26.7 million ($0.52 per diluted share) from $30.1 million ($0.59 per diluted share) in Q1 2024. The company's engineering segment, representing 84% of revenues, remained flat, while the environmental and health segment grew 2%. EBITDA declined to $37.5 million (27.3% of net revenues) from $40.1 million. The company announced a quarterly dividend of $0.30 per share and maintained its 2025 guidance, expecting low-single-digit revenue growth despite facing Q2 headwinds. Exponent's performance was driven by increased dispute-related activities in chemicals, transportation, and utilities industries, though impacted by slowdown in consumer electronics.

Exponent Inc (Nasdaq: EXPO) has scheduled its First Quarter Fiscal Year 2025 financial results announcement for May 1, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on the same day.

CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will lead the discussion of the company's business and financial results for the period ended April 4, 2025. Investors can access the call through dial-in numbers (844) 481-2781 or (412) 317-0672.

A live and archived webcast will be available through the company's Investor Relations website. A replay of the call will be accessible until May 8, 2025, via (877) 344-7529 or (412) 317-0088 with passcode 8332346#.

Exponent (NASDAQ: EXPO) has announced a 7.1% increase in its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The dividend will be paid on March 21, 2025, to stockholders of record as of March 7, 2025.

This marks the 12th consecutive year of dividend increases for the company. Exponent maintains a quarterly dividend schedule, with payments in March, June, September, and December, subject to Board approval. CEO Dr. Catherine Corrigan highlighted the company's commitment to shareholder value, emphasizing their diverse services portfolio and aligned operating model as key factors positioning them for market growth.

Exponent (NASDAQ: EXPO) reported strong Q4 and fiscal year 2024 results, with total Q4 revenues increasing 11.3% to $136.8 million and revenues before reimbursements rising 8.7% to $123.8 million. Q4 net income grew to $23.6 million ($0.46 per diluted share), up from $20.9 million ($0.41 per diluted share) in Q4 2023.

For fiscal year 2024, total revenues increased 4.1% to $558.5 million, with net income reaching $109.0 million ($2.11 per diluted share). The company achieved growth across both proactive and reactive services, particularly in consumer electronics, utilities, and medical devices. EBITDA margin improved to 28.4% of revenues before reimbursements.

The company increased its quarterly dividend from $0.28 to $0.30 and ended the year with $258.9 million in cash. Looking ahead to 2025, Exponent expects low single-digit revenue growth despite a 5-6% headwind in technical full-time-equivalent employees.

Exponent (NASDAQ: EXPO) has scheduled its Fourth Quarter and fiscal year 2024 financial results announcement for Thursday, February 6, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on the same day.

CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will lead the discussion of the company's business and financial results for the period ended January 3, 2025. Investors can access the live call through designated phone numbers or view the webcast through Exponent's Investor Relations website. A telephonic replay will be available until February 13, 2025.

Exponent (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share for Q4 2024, payable on December 20, 2024, to stockholders of record as of December 6, 2024. The company maintains its quarterly dividend schedule in March, June, September, and December, subject to Board approval. CEO Dr. Catherine Corrigan emphasized the company's commitment to shareholders, highlighting their diverse services portfolio and aligned operating model as key factors in capturing market demand and delivering long-term value.

Exponent (NASDAQ: EXPO) reported Q3 2024 financial results with flat revenues before reimbursements at $125.1 million, while total revenues increased 2% to $136.3 million. Net income grew 6% to $26.0 million ($0.50 per diluted share), and EBITDA margin expanded by 100 basis points to 28.6%. The company saw healthy rebound in consumer electronics sector, offset by challenges in chemicals. Year-to-date results showed 3% growth in revenues before reimbursements to $394.7 million, with net income of $85.4 million ($1.66 per diluted share). The company maintained revenue guidance and raised margin guidance for full-year 2024.

Exponent, Inc. (Nasdaq: EXPO) has announced it will report its Third Quarter of fiscal year 2024 financial results on Thursday, October 24, 2024, after market close. The results will cover the period ended September 27, 2024. Following the release, the company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the business and financial results.

The call will be led by Dr. Catherine Corrigan, CEO and President, and Richard Schlenker, Executive VP and CFO. Investors can join the live call at (844) 481-2781 or (412) 317-0672. A live and archived webcast will be available from the Investor Relations section of Exponent's website. A telephonic replay will be accessible until October 31, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 1389454#.

Exponent, Inc. (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share of common stock, payable on September 20, 2024, to stockholders of record as of September 6, 2024. The company maintains its practice of paying quarterly dividends in March, June, September, and December. Dr. Catherine Corrigan, President and CEO, emphasized Exponent's commitment to shareholders through this dividend, citing strong market drivers and strategic positioning as enablers of sustainable long-term growth. Future dividend declarations remain subject to the Board of Directors' final determination.